| Bioactivity | IACS-52825 is a potent and selective DLK inhibitor with Kd of 1.3 nM, useful for the study of chemotherapy-induced peripheral neuropathy[1]. |
| Name | IACS-52825 |
| CAS | 2640376-72-1 |
| Formula | C16H13F7N4O2 |
| Molar Mass | 426.29 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kang Le, et al. Discovery of IACS-52825, a Potent and Selective DLK Inhibitor for Treatment of Chemotherapy-Induced Peripheral Neuropathy. J Med Chem. 2023 Jul 27;66(14):9954-9971. |
IACS-52825
CAS: 2640376-72-1 F: C16H13F7N4O2 W: 426.29
IACS-52825 is a potent and selective DLK inhibitor with Kd of 1.3 nM, useful for the study of chemotherapy-induced perip
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.